<DOC>
	<DOCNO>NCT01267175</DOCNO>
	<brief_summary>The user evaluation ass user acceptance quality training material MiniMed Paradigm® X54 System ( X54 System ) preparation commercial distribution new system .</brief_summary>
	<brief_title>United Kingdom User Evaluation , MiniMed Paradigm® X54 System</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Are current 512/712 , 515/715 522/722 MiniMed Paradigm Insulin Pump user , without CGM experience , least three month experience one device ; Have sign Informed Consent willing comply user evaluation procedure ; Have HbA1c value le 9.0 % record time last test ( HbA1c value available within three month enrollment , HbA1c perform prior entry verify inclusion criterion ) ; Are willing use Bolus Wizard feature ; Agree complete diary duration study ; Agree complete questionnaire conclusion study ; Have diagnose Type 1 Diabetes Mellitus appropriate fasting non fast lab blood glucose value , cpeptide , insulin antibody , prior document DKA good clinical picture least six month prior study start ; Are 18 65 year age ; Have access internet agree upload device per protocol Is pregnant plan become pregnant course user evaluation . Pregnancy screen complete routine office visit prior evaluation study . If woman become pregnant participation , withdrawn ; Suffers chronic debilitate condition ; Has serious unstable medical psychological condition ( e.g. , eat disorder , clinical depression , anxiety disorder ) , opinion Investigator , would compromise subject 's safety successful participation study ; Has impair vision hearing problem could compromise handle device ; Has history tape allergies skin condition could interfere continue use system ; Has potential lack compliance issue , opinion Investigator , may preclude subject satisfactory participation study ; Has travel plan would make difficult subject attend onsite study visit schedule ; Is currently participate investigational study ( drug device ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>